{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:36:54Z","timestamp":1780090614628,"version":"3.54.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lundbeck Foundation grant","award":["R303-2018-3148"],"award-info":[{"award-number":["R303-2018-3148"]}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK119293"],"award-info":[{"award-number":["R01DK119293"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Akiko Yamazaki and Jerry Yang 20 Faculty Scholarship"},{"name":"the Stanford Maternal and Child Health Research Institute"},{"DOI":"10.13039\/100014499","name":"SDRC","doi-asserted-by":"crossref","award":["P30DK116074"],"award-info":[{"award-number":["P30DK116074"]}],"id":[{"id":"10.13039\/100014499","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Diabetes and Digestive and Kidney Diseases,United States","award":["R01DK141802"],"award-info":[{"award-number":["R01DK141802"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mesenchymal stem cells (MSCs) represent a promising regenerative therapy associated with anti-inflammatory, anti-apoptotic, and pro-proliferative properties. Despite their significant potential for treating diabetes, the clinical application of MSCs has been hindered mainly due to the low number of intravenously (IV) injected cells that successfully reach the pancreas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we assessed the protective potential of adipose tissue-derived MSCs (AD-MSCs) in preventing the development of diabetes using a streptozotocin (STZ)-induced diabetic rat model. AD-MSCs were administered 4\u00a0h after STZ either via conventional IV injection or through direct intra-arterial (IA) administration into the pancreas. Healthy (no STZ, no MSCs) and diabetic (STZ, no MSCs) control groups were also included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our proof-of-concept data indicate that IA administration of AD-MSCs allowed rats to maintain glycemic control and respond appropriately to glucose challenges following STZ treatment, comparable to healthy controls. In contrast, rats receiving IV AD-MSCs developed hyperglycemia and failed to respond adequately to glucose challenges. In vitro studies demonstrated that AD-MSCs can enhance the viability and function (i.e. insulin secretion) of injured islets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Local IA delivery of AD-MSCs into the pancreatic circulation effectively prevents the onset of diabetes in a preclinical rat model, highlighting the need for considering delivery techniques to ensure MSCs can reach their targets in vivo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04807-3","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:54:52Z","timestamp":1763866492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preventing the onset of diabetes with precision delivery of mesenchymal stem cells to the pancreas in a preclinical model"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-1937","authenticated-orcid":false,"given":"Reza","family":"Yarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Primavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Haupt-Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Pociot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avnesh S.","family":"Thakor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"4807_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12:87\u2013117. https:\/\/doi.org\/10.1146\/annurev-bioeng-070909-105309.","journal-title":"Annu Rev Biomed Eng"},{"key":"4807_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, et al. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34:747. https:\/\/doi.org\/10.1038\/aps.2013.50.","journal-title":"Acta Pharmacol Sin"},{"key":"4807_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4252\/wjsc.v6.i2.163","volume":"6","author":"M Figliuzzi","year":"2014","unstructured":"Figliuzzi M, Bonandrini B, Silvani S, Remuzzi A. Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells. 2014;6:163\u201372. https:\/\/doi.org\/10.4252\/wjsc.v6.i2.163.","journal-title":"World J Stem Cells"},{"key":"4807_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","volume":"64","author":"PO Carlsson","year":"2015","unstructured":"Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K. Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015;64:587\u201392. https:\/\/doi.org\/10.2337\/db14-0656.","journal-title":"Diabetes"},{"key":"4807_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","volume":"60","author":"J Hu","year":"2013","unstructured":"Hu J, et al. Long term effects of the implantation of wharton\u2019s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J. 2013;60:347\u201357.","journal-title":"Endocr J"},{"key":"4807_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s42003-025-08244-z","volume":"8","author":"V Sood","year":"2025","unstructured":"Sood V, et al. Adipose-derived mesenchymal stromal\/stem cells in type 1 diabetes treatment. Commun Biol. 2025;8:1094. https:\/\/doi.org\/10.1038\/s42003-025-08244-z.","journal-title":"Commun Biol"},{"key":"4807_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/RLU.0000000000000850","volume":"40","author":"V Sood","year":"2015","unstructured":"Sood V, et al. Biodistribution of 18F-FDG-Labeled autologous bone Marrow-Derived stem cells in patients with type 2 diabetes mellitus: exploring targeted and intravenous routes of delivery. Clin Nucl Med. 2015;40:697\u2013700. https:\/\/doi.org\/10.1097\/RLU.0000000000000850.","journal-title":"Clin Nucl Med"},{"key":"4807_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.transproceed.2006.12.019","volume":"39","author":"S Schrepfer","year":"2007","unstructured":"Schrepfer S, et al. Stem cell transplantation: the lung barrier. Transpl Proc. 2007;39:573\u20136. https:\/\/doi.org\/10.1016\/j.transproceed.2006.12.019.","journal-title":"Transpl Proc"},{"key":"4807_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/MPA.0000000000001100","volume":"47","author":"J Choi","year":"2018","unstructured":"Choi J, Wang J, Ren G, Thakor AS. A novel approach for therapeutic delivery to the rodent pancreas via its arterial blood supply. Pancreas. 2018;47:910\u20135. https:\/\/doi.org\/10.1097\/MPA.0000000000001100.","journal-title":"Pancreas"},{"key":"4807_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/stcltm\/szae020","volume":"13","author":"R Primavera","year":"2024","unstructured":"Primavera R, et al. Precision delivery of human bone Marrow-Derived mesenchymal stem cells into the pancreas via Intra-arterial injection prevents the onset of diabetes. Stem Cells Transl Med. 2024;13:559\u201371. https:\/\/doi.org\/10.1093\/stcltm\/szae020.","journal-title":"Stem Cells Transl Med"},{"key":"4807_CR11","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine Society, and the American diabetes association. Diabetes Care. 2015;38:1964\u201374. https:\/\/doi.org\/10.2337\/dc15-1419.","journal-title":"Diabetes Care"},{"key":"4807_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/00007890-200202270-00004","volume":"73","author":"K Ikebukuro","year":"2002","unstructured":"Ikebukuro K, et al. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats. Transplantation. 2002;73:512\u20138. https:\/\/doi.org\/10.1097\/00007890-200202270-00004.","journal-title":"Transplantation"},{"key":"4807_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbrc.2017.03.054","volume":"486","author":"S Bathina","year":"2017","unstructured":"Bathina S, Srinivas N, Das UN. Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats. Biochem Biophys Res Commun. 2017;486:406\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.054.","journal-title":"Biochem Biophys Res Commun"},{"key":"4807_CR14","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.4049\/jimmunol.1502494","volume":"197","author":"S Niu","year":"2016","unstructured":"Niu S, et al. Broad infiltration of macrophages leads to a Proinflammatory state in Streptozotocin-Induced hyperglycemic mice. J Immunol. 2016;197:3293\u2013301. https:\/\/doi.org\/10.4049\/jimmunol.1502494.","journal-title":"J Immunol"},{"key":"4807_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2337\/diabetes.49.7.1131","volume":"49","author":"M Kullin","year":"2000","unstructured":"Kullin M, et al. K(ATP) channel openers protect rat Islets against the toxic effect of streptozotocin. Diabetes. 2000;49:1131\u20136. https:\/\/doi.org\/10.2337\/diabetes.49.7.1131.","journal-title":"Diabetes"},{"key":"4807_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0014-2999(02)02389-0","volume":"453","author":"M Matsuda","year":"2002","unstructured":"Matsuda M, et al. Rescue of beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes. Eur J Pharmacol. 2002;453:141\u20138. https:\/\/doi.org\/10.1016\/s0014-2999(02)02389-0.","journal-title":"Eur J Pharmacol"},{"key":"4807_CR17","doi-asserted-by":"publisher","first-page":"108765","DOI":"10.1016\/j.biopha.2019.108765","volume":"114","author":"Z Si","year":"2019","unstructured":"Si Z, et al. Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother. 2019;114:108765. https:\/\/doi.org\/10.1016\/j.biopha.2019.108765.","journal-title":"Biomed Pharmacother"},{"key":"4807_CR18","doi-asserted-by":"publisher","unstructured":"Zhang J et al. Adipose-derived stem cells: current applications and future directions in the regeneration of multiple tissues. Stem Cells Int 2020, 8810813 (2020). https:\/\/doi.org\/10.1155\/2020\/8810813","DOI":"10.1155\/2020\/8810813"},{"key":"4807_CR19","doi-asserted-by":"publisher","unstructured":"Rochette L, et al. The crosstalk of Adipose-Derived stem cells (ADSC), oxidative Stress, and inflammation in protective and adaptive responses. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21239262.","DOI":"10.3390\/ijms21239262"},{"key":"4807_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fcell.2020.00236","volume":"8","author":"S Ceccarelli","year":"2020","unstructured":"Ceccarelli S, Pontecorvi P, Anastasiadou E, Napoli C, Marchese C. Immunomodulatory effect of Adipose-Derived stem cells: the cutting edge of clinical application. Front Cell Dev Biol. 2020;8:236. https:\/\/doi.org\/10.3389\/fcell.2020.00236.","journal-title":"Front Cell Dev Biol"},{"key":"4807_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3892\/etm.2015.2505","volume":"10","author":"W Yao","year":"2015","unstructured":"Yao W, et al. Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways. Exp Ther Med. 2015;10:468\u201376. https:\/\/doi.org\/10.3892\/etm.2015.2505.","journal-title":"Exp Ther Med"},{"key":"4807_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tox.2010.10.011","volume":"279","author":"S Lu","year":"2011","unstructured":"Lu S, et al. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K\/Akt activation. Toxicology. 2011;279:189\u201395. https:\/\/doi.org\/10.1016\/j.tox.2010.10.011.","journal-title":"Toxicology"},{"key":"4807_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3727\/096368915x688155","volume":"25","author":"J Zhang","year":"2016","unstructured":"Zhang J, et al. Adipose-Derived mesenchymal stem cells (ADSCs) with the potential to ameliorate platelet Recovery, enhance Megakaryopoiesis, and inhibit apoptosis of bone marrow cells in a mouse model of Radiation-Induced thrombocytopenia. Cell Transplant. 2016;25:261\u201373. https:\/\/doi.org\/10.3727\/096368915x688155.","journal-title":"Cell Transplant"},{"key":"4807_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000448180","volume":"43","author":"L Frese","year":"2016","unstructured":"Frese L, Dijkman PE, Hoerstrup SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemotherapy. 2016;43:268\u201374.","journal-title":"Transfus Med Hemotherapy"},{"key":"4807_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8:315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"4807_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.stemcr.2022.11.006","volume":"18","author":"A Ganguly","year":"2023","unstructured":"Ganguly A, et al. Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signature. Stem Cell Rep. 2023;18:190\u2013204. https:\/\/doi.org\/10.1016\/j.stemcr.2022.11.006.","journal-title":"Stem Cell Rep"},{"key":"4807_CR27","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1038\/s41598-023-29445-8","volume":"13","author":"HU Rehman","year":"2023","unstructured":"Rehman HU, et al. Comparative impact of streptozotocin on altering normal glucose homeostasis in diabetic rats compared to normoglycemic rats. Sci Rep. 2023;13:7921. https:\/\/doi.org\/10.1038\/s41598-023-29445-8.","journal-title":"Sci Rep"},{"key":"4807_CR28","doi-asserted-by":"publisher","first-page":"e0281692","DOI":"10.1371\/journal.pone.0281692","volume":"18","author":"L Pourmousavi","year":"2023","unstructured":"Pourmousavi L, Asadi H, Zehsaz R, F., Jadidi RP. Effect of Crocin and treadmill exercise on oxidative stress and heart damage in diabetic rats. PLoS ONE. 2023;18:e0281692. https:\/\/doi.org\/10.1371\/journal.pone.0281692.","journal-title":"PLoS ONE"},{"key":"4807_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41387-022-00211-5","volume":"12","author":"MG Rad","year":"2022","unstructured":"Rad MG, Sharifi M, Meamar R, Soltani N. The role of pancreas to improve hyperglycemia in STZ-induced diabetic rats by thiamine disulfide. Nutr Diabetes. 2022;12:32. https:\/\/doi.org\/10.1038\/s41387-022-00211-5.","journal-title":"Nutr Diabetes"},{"key":"4807_CR30","doi-asserted-by":"publisher","first-page":"15929","DOI":"10.1038\/s41598-019-52490-1","volume":"9","author":"M Rezaee","year":"2019","unstructured":"Rezaee M, et al. A study comparing the effects of targeted Intra-Arterial and systemic chemotherapy in an orthotopic mouse model of pancreatic cancer. Sci Rep. 2019;9:15929. https:\/\/doi.org\/10.1038\/s41598-019-52490-1.","journal-title":"Sci Rep"},{"key":"4807_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12575-021-00143-x","volume":"23","author":"KL Corbin","year":"2021","unstructured":"Corbin KL, et al. A practical guide to rodent islet isolation and assessment revisited. Biol Procedures Online. 2021;23:7. https:\/\/doi.org\/10.1186\/s12575-021-00143-x.","journal-title":"Biol Procedures Online"},{"key":"4807_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/dmso.S82272","volume":"8","author":"J Wu","year":"2015","unstructured":"Wu J, Yan LJ. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic \u03b2 cell glucotoxicity. Diabetes Metab Syndr Obes. 2015;8:181\u20138. https:\/\/doi.org\/10.2147\/dmso.S82272.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4807_CR33","doi-asserted-by":"publisher","DOI":"10.1258\/la.2010.010090","author":"M Deeds","year":"2011","unstructured":"Deeds M, et al. Single dose Streptozotocin-Induced diabetes: considerations for study design in islet transplantation models. Lab Anim. 2011. https:\/\/doi.org\/10.1258\/la.2010.010090.","journal-title":"Lab Anim"},{"key":"4807_CR34","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1210863","author":"CG \u00d6stenson","year":"2009","unstructured":"\u00d6stenson CG, Grill V, Roos M. Studies on sex dependency of B-Cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus. Exp Clin Endocrinol Diabetes. 2009. https:\/\/doi.org\/10.1055\/s-0029-1210863.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4807_CR35","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00204.2005","author":"SB Gurley","year":"2006","unstructured":"Gurley SB, et al. Impact of genetic background on nephropathy in diabetic mice. Ajp Ren Physiol. 2006. https:\/\/doi.org\/10.1152\/ajprenal.00204.2005.","journal-title":"Ajp Ren Physiol"},{"key":"4807_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/0023677217747915","author":"SA N\u00f8rgaard","year":"2018","unstructured":"N\u00f8rgaard SA, Sand FW, S\u00f8rensen DB, Abelson KSP, S\u00f8ndergaard H. Softened food reduces weight loss in the Streptozotocin-Induced male mouse model of diabetic nephropathy. Lab Anim. 2018. https:\/\/doi.org\/10.1177\/0023677217747915.","journal-title":"Lab Anim"},{"key":"4807_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13765-020-00547-5","author":"B Kim","year":"2020","unstructured":"Kim B, Kim YY, Nguyen PT, Nam H, Suh J-G. Sex differences in glucose metabolism of Streptozotocin-Induced diabetes inbred mice (C57bl\/6j). Appl Biol Chem. 2020. https:\/\/doi.org\/10.1186\/s13765-020-00547-5.","journal-title":"Appl Biol Chem"},{"key":"4807_CR38","first-page":"2147","volume":"14","author":"AML Chan","year":"2022","unstructured":"Chan AML, Sampasivam Y, Lokanathan Y. Biodistribution of mesenchymal stem cells (MSCs) in animal models and implied role of exosomes following systemic delivery of mscs: a systematic review. Am J Transl Res. 2022;14:2147\u201361.","journal-title":"Am J Transl Res"},{"key":"4807_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2019.05.004","volume":"14","author":"M Salvadori","year":"2019","unstructured":"Salvadori M, et al. Dissecting the pharmacodynamics and pharmacokinetics of MSCs to overcome limitations in their clinical translation. Mol Ther Methods Clin Dev. 2019;14:1\u201315. https:\/\/doi.org\/10.1016\/j.omtm.2019.05.004.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4807_CR40","doi-asserted-by":"publisher","unstructured":"Gao S, Zhang Y, Liang K, Bi R, Du Y. Mesenchymal stem cells (MSCs): A novel therapy for type 2 diabetes. Stem Cells Int. 2022;2022(8637493). https:\/\/doi.org\/10.1155\/2022\/8637493.","DOI":"10.1155\/2022\/8637493"},{"key":"4807_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.12816\/0023128","volume":"44","author":"M Morsy","year":"2015","unstructured":"Morsy M, Ameen SM, Atwa AM, M., Mohamed I, Role of adipose m, derived mesenchymal stem cells in improving streptozotocin-induced diabetes mellitus in rats. Al-Azhar Med J. 2015;44:279\u201393. https:\/\/doi.org\/10.12816\/0023128.","journal-title":"Al-Azhar Med J"},{"key":"4807_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/5584_2017_127","volume":"1083","author":"LT Dang","year":"2018","unstructured":"Dang LT, et al. Intravenous infusion of human adipose Tissue-Derived mesenchymal stem cells to treat type 1 diabetic mellitus in mice: an evaluation of grafted cell doses. Adv Exp Med Biol. 2018;1083:145\u201356. https:\/\/doi.org\/10.1007\/5584_2017_127.","journal-title":"Adv Exp Med Biol"},{"key":"4807_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0005-2728(99)00029-8","volume":"1411","author":"MP Murphy","year":"1999","unstructured":"Murphy MP. Nitric oxide and cell death. Biochim Et Biophys Acta (BBA) - Bioenergetics. 1999;1411:401\u201314.","journal-title":"Biochim Et Biophys Acta (BBA) - Bioenergetics"},{"key":"4807_CR44","first-page":"481","volume":"5","author":"D Ash","year":"2015","unstructured":"Ash D, Subramanian M, Surolia A, Shaha C. Nitric oxide is the key mediator of death induced by Fisetin in human acute monocytic leukemia cells. Am J Cancer Res. 2015;5:481\u201397.","journal-title":"Am J Cancer Res"},{"key":"4807_CR45","doi-asserted-by":"publisher","first-page":"10845","DOI":"10.1073\/pnas.191207498","volume":"98","author":"S Oyadomari","year":"2001","unstructured":"Oyadomari S, et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the Endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A. 2001;98:10845\u201350. https:\/\/doi.org\/10.1073\/pnas.191207498.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4807_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00109-011-0747-1","volume":"89","author":"E Gurgul-Convey","year":"2011","unstructured":"Gurgul-Convey E, Mehmeti I, Lortz S, Lenzen S. Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria. J Mol Med (Berl). 2011;89:785\u201398. https:\/\/doi.org\/10.1007\/s00109-011-0747-1.","journal-title":"J Mol Med (Berl)"},{"key":"4807_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2337\/diab.44.7.733","volume":"44","author":"H Kaneto","year":"1995","unstructured":"Kaneto H, et al. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes. 1995;44:733\u20138. https:\/\/doi.org\/10.2337\/diab.44.7.733.","journal-title":"Diabetes"},{"key":"4807_CR48","doi-asserted-by":"publisher","unstructured":"Quintana-Lopez L, et al. Nitric oxide is a mediator of antiproliferative effects induced by Proinflammatory cytokines on pancreatic beta cells. Mediators Inflamm. 2013;2013(905175). https:\/\/doi.org\/10.1155\/2013\/905175.","DOI":"10.1155\/2013\/905175"},{"key":"4807_CR49","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41467-023-36148-1","volume":"14","author":"K Kulaj","year":"2023","unstructured":"Kulaj K, et al. Adipocyte-derived extracellular vesicles increase insulin secretion through transport of insulinotropic protein cargo. Nat Commun. 2023;14:709. https:\/\/doi.org\/10.1038\/s41467-023-36148-1.","journal-title":"Nat Commun"},{"key":"4807_CR50","doi-asserted-by":"publisher","unstructured":"Jiao Z et al. Protective Effect of Adipose-Derived Mesenchymal Stem Cell Secretome against Hepatocyte Apoptosis Induced by Liver Ischemia-Reperfusion with Partial Hepatectomy Injury. Stem Cells Int 2021, 9969372 (2021). https:\/\/doi.org\/10.1155\/2021\/9969372","DOI":"10.1155\/2021\/9969372"},{"key":"4807_CR51","doi-asserted-by":"publisher","first-page":"122761","DOI":"10.1016\/j.lfs.2024.122761","volume":"351","author":"A Kostecka","year":"2024","unstructured":"Kostecka A, et al. Adipose-derived mesenchymal stromal cells in clinical trials: insights from single-cell studies. Life Sci. 2024;351:122761. https:\/\/doi.org\/10.1016\/j.lfs.2024.122761.","journal-title":"Life Sci"},{"key":"4807_CR52","doi-asserted-by":"publisher","unstructured":"Czerwiec K, et al. Adipose-Derived mesenchymal stromal cells in basic research and clinical applications. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24043888.","DOI":"10.3390\/ijms24043888"},{"key":"4807_CR53","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-025-04405-3","volume":"16","author":"H Su","year":"2025","unstructured":"Su H, et al. Bridging the gap: clinical translation of adipose-derived stem cells - a scoping review of clinical trials. Stem Cell Res Ther. 2025;16:288. https:\/\/doi.org\/10.1186\/s13287-025-04405-3.","journal-title":"Stem Cell Res Ther"},{"key":"4807_CR54","doi-asserted-by":"publisher","unstructured":"Jackson MV et al. Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS. Stem Cells 34, 2210\u20132223 (2016). https:\/\/doi.org\/10.1002\/stem.2372","DOI":"10.1002\/stem.2372"},{"key":"4807_CR55","doi-asserted-by":"publisher","unstructured":"Mohammadalipour A, Dumbali SP, Wenzel PL. Mitochondrial transfer and regulators of mesenchymal stromal cell function and therapeutic efficacy. Front Cell Dev Biology. 2020;8. https:\/\/doi.org\/10.3389\/fcell.2020.603292.","DOI":"10.3389\/fcell.2020.603292"},{"key":"4807_CR56","doi-asserted-by":"publisher","first-page":"113482","DOI":"10.1016\/j.biopha.2022.113482","volume":"153","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu Q, Hu H, Zhao L, Zhu K. Progress in mesenchymal stem cell mitochondria transfer for the repair of tissue injury and treatment of disease. Biomed Pharmacother. 2022;153:113482. https:\/\/doi.org\/10.1016\/j.biopha.2022.113482.","journal-title":"Biomed Pharmacother"},{"key":"4807_CR57","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/stem.3134","volume":"38","author":"CL Rackham","year":"2020","unstructured":"Rackham CL, et al. Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer. Stem Cells. 2020;38:574\u201384. https:\/\/doi.org\/10.1002\/stem.3134.","journal-title":"Stem Cells"},{"key":"4807_CR58","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/sctm.20-0466","volume":"10","author":"EL Hubber","year":"2021","unstructured":"Hubber EL, Rackham CL, Jones PM. Protecting islet functional viability using mesenchymal stromal cells. Stem Cells Transl Med. 2021;10:674\u201380. https:\/\/doi.org\/10.1002\/sctm.20-0466.","journal-title":"Stem Cells Transl Med"},{"key":"4807_CR59","doi-asserted-by":"publisher","unstructured":"Barachini S, et al. Mesenchymal stem cell in pancreatic islet transplantation. Biomedicines. 2023;11. https:\/\/doi.org\/10.3390\/biomedicines11051426.","DOI":"10.3390\/biomedicines11051426"},{"key":"4807_CR60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5966\/sctm.2012-0116","volume":"2","author":"P Chhabra","year":"2013","unstructured":"Chhabra P, Brayman KL. Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med. 2013;2:328\u201336. https:\/\/doi.org\/10.5966\/sctm.2012-0116.","journal-title":"Stem Cells Transl Med"},{"key":"4807_CR61","doi-asserted-by":"publisher","unstructured":"Ba\u010denkov\u00e1 D, et al. Interaction between mesenchymal stem cells and the immune system in rheumatoid arthritis. Pharmaceuticals (Basel). 2022;15. https:\/\/doi.org\/10.3390\/ph15080941.","DOI":"10.3390\/ph15080941"},{"key":"4807_CR62","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53:e12712. https:\/\/doi.org\/10.1111\/cpr.12712.","journal-title":"Cell Prolif"},{"key":"4807_CR63","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00125-022-05708-3","volume":"65","author":"E Kawada-Horitani","year":"2022","unstructured":"Kawada-Horitani E, et al. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint Blockade. Diabetologia. 2022;65:1185\u201397. https:\/\/doi.org\/10.1007\/s00125-022-05708-3.","journal-title":"Diabetologia"},{"key":"4807_CR64","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.crphar.2021.100069","volume":"2","author":"I Dias","year":"2021","unstructured":"Dias I, et al. Secretome effect of adipose tissue-derived stem cells cultured two-dimensionally and three-dimensionally in mice with Streptozocin induced type 1 diabetes. Curr Res Pharmacol Drug Discov. 2021;2:100069. https:\/\/doi.org\/10.1016\/j.crphar.2021.100069.","journal-title":"Curr Res Pharmacol Drug Discov"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04807-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04807-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04807-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:58:36Z","timestamp":1767045516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04807-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4807"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04807-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that all experiments in the present study were approved by the Administrative Panel on Laboratory Animal Care at Stanford University and were carried out per the Institutional Animal Care and Use Committee (IACUC) approval (Title: Targeting cellular therapy using pulsed focused ultrasound: A novel application to treat diabetes; Approval number: 31947; Last Approval date: 10\/15\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"687"}}